Related Experiment Video
Updated: Mar 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Mutation Screening of Gata4 Gene in CTD Patients Within Chinese Han Population
Yang Liu1, Bojian Li1, Yuejuan Xu1
1Department of Pediatric Cardiology, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Insights
This study investigated GATA4 gene mutations in Chinese Han patients with conotruncal heart defect (CTD). While several variants were identified, the novel A167D mutation did not alter GATA4 protein function, suggesting other CTD mechanisms.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Conotruncal heart defect (CTD) is a severe congenital heart disease with a poor prognosis.
- Previous studies suggested GATA4 gene missense variants may contribute to CTD, but lacked sufficient evidence due to limited study populations.
- Understanding the genetic basis of CTD is crucial for improving diagnosis and treatment.
Purpose of the Study:
- To investigate GATA4 gene mutations in isolated CTD Chinese Han patients.
- To identify the pathomechanism of identified GATA4 missense mutations.
- To evaluate the functional impact of a novel GATA4 variant (p.A167D).
Main Methods:
- Sequencing of GATA4 coding exons and exon-intron boundaries in 600 CTD patients and 300 controls.
- In silico analysis of the novel GATA4 variant (p.A167D) using PolyPhen 2 and SIFT.
- Functional assays including luciferase reporter assay and Western blot to assess mutant GATA4 protein activity.
Main Results:
- Eight heterozygous nonsynonymous GATA4 variants were identified in 22 CTD patients.
- A novel variant, p.A167D, was identified and predicted to affect protein function by in silico tools.
- Functional analyses showed no significant alteration in transcriptional activity or protein levels for the A167D mutant GATA4.
Conclusions:
- The identified GATA4 variants, including the novel A167D mutation, may not be the primary cause of CTD in this cohort.
- The pathomechanism of CTD in these patients might involve other genetic or environmental factors.
- Further research is needed to elucidate the complex etiology of conotruncal heart defects.
Abstract:
Conotruncal heart defect is a complex form of congenital heart disease and usually has a poor prognosis. Although previous studies have identified several missense variants in GATA4 gene that may cause CTD, it remains unclear whether they are involved in CTD pathogenesis because the study population was limited. The aim of the study was to investigate the mutations of GATA4 gene in isolated CTD Chinese Han patients and identify the pathomechanism of the missense mutations. In this report, the coding exons and exon-intron boundaries of the GATA4 gene were sequenced in 600 CTD patients and 300 controls. Functional significance of the novel GATA4 gene mutation (p.A167D) was analyzed using PolyPhen 2 and SIFT. And, the functional characteristics of the mutant GATA4 gene were assayed in contrast to its wild-type counterpart using a luciferase reporter assay system as well as Western blot. Eight heterozygous nonsynonymous variants (V380M, G64E, A167D, V267M, S377G, P163S, P407Q, A66T) were found in 22 patients, of which one (A167D) was reported here for the first time and five (G64E, A167D, S377G, P163S, A66T) were only found in CTD patients when compared with 300 controls. The PolyPhen 2 and SIFT programs predicted that the A167D substitution was expected to influence protein function. Subsequent functional analyses revealed that the transcriptional activity and Western blot of A167D mutant GATA4 protein were not altered. These variants may be involved in other mechanisms underlying CTD or may be unrelated to CTD occurrence.
More Related Videos
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

